We are live on ! Find out more
SC

Stralem & Co Portfolio holdings

AUM $157M
1-Year Est. Return 4.29%
This Fund
S&P 500
This Quarter Est. Return
+2.85%
1 Year Est. Return
+4.29%
3 Year Est. Return
+25.48%
5 Year Est. Return
+55.56%
10 Year Est. Return
–
AUM
$589M
AUM Growth
-$106M
Cap. Flow
-$122M
Cap. Flow %
-20.75%
Top 10 Hldgs %
35.02%
Holding
47
New
–
Increased
7
Reduced
38
Closed
2

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$3.8M
2
APTV icon
Aptiv
APTV
+$3.06M
3
MDLZ icon
Mondelez International
MDLZ
+$1.21M
4
MRK icon
Merck
MRK
+$467K
5
ZBH icon
Zimmer Biomet
ZBH
+$186K

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$18.7M
2
JCI icon
Johnson Controls International
JCI
+$18.4M
3
ADBE icon
Adobe
ADBE
+$8.27M
4
MSFT icon
Microsoft
MSFT
+$7.09M
5
UNH icon
UnitedHealth
UNH
+$6.93M

Sector Composition

Rank Sector Weight
1 Healthcare 26%
2 Technology 12.49%
3 Consumer Discretionary 10.77%
4 Communication Services 9.84%
5 Consumer Staples 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
26
Johnson & Johnson
JNJ
$629B
$14.5M 2.47%
104,020
-3,240
-3% -$451K
CELG
27
DELISTED
Celgene Corp
CELG
$14.1M 2.4%
135,243
+33,660
+33% +$3.8M
TMO icon
28
Thermo Fisher Scientific
TMO
$223B
$14M 2.37%
73,490
-4,245
-5% -$813K
EOG icon
29
EOG Resources
EOG
$75.1B
$13.9M 2.36%
128,730
-25,430
-16% -$2.56M
CB icon
30
Chubb
CB
$132B
$12.6M 2.13%
85,995
-16,350
-16% -$2.44M
AMGN icon
31
Amgen
AMGN
$225B
$12.2M 2.07%
70,135
-11,720
-14% -$2.07M
CVX icon
32
Chevron
CVX
$386B
$12.2M 2.07%
97,195
-30,450
-24% -$3.61M
XOM icon
33
ExxonMobil
XOM
$657B
$12.1M 2.05%
144,353
-21,767
-13% -$1.8M
BMY icon
34
Bristol-Myers Squibb
BMY
$130B
$2.51M 0.43%
40,900
-10,000
-20% -$625K
KO icon
35
Coca-Cola
KO
$373B
$1.29M 0.22%
28,200
-5,400
-16% -$248K
ZBH icon
36
Zimmer Biomet
ZBH
$18.7B
$1M 0.17%
8,549
+1,648
+24% +$186K
A icon
37
Agilent Technologies
A
$41.9B
$964K 0.16%
14,400
-2,400
-14% -$162K
COST icon
38
Costco
COST
$421B
$931K 0.16%
5,000
-1,300
-21% -$224K
ADP icon
39
Automatic Data Processing
ADP
$107B
$926K 0.16%
7,900
-2,600
-25% -$297K
IFF icon
40
International Flavors & Fragrances
IFF
$21.4B
$916K 0.16%
6,000
-1,500
-20% -$225K
GILD icon
41
Gilead Sciences
GILD
$168B
$910K 0.15%
12,700
+600
+5% +$45.6K
LLY icon
42
Eli Lilly
LLY
$1.09T
$895K 0.15%
10,600
-2,600
-20% -$221K
FE icon
43
FirstEnergy
FE
$27.2B
$885K 0.15%
28,900
-8,200
-22% -$266K
NVDA icon
44
NVIDIA
NVDA
$5.43T
$813K 0.14%
168,000
-68,000
-29% -$338K
AAPL icon
45
Apple
AAPL
$4.41T
$778K 0.13%
18,400
-7,200
-28% -$301K
DIS icon
46
Walt Disney
DIS
$178B
– –
-189,670
Closed -$18.7M
JCI icon
47
Johnson Controls International
JCI
$92.6B
– –
-457,829
Closed -$18.4M
1
2

Similar funds

LI
Leap Investments Chicago, Illinois $152M AUM 3.6% 1-Year Est. Return
BC
Blackstart Capital New York $151M AUM 14.01% 1-Year Est. Return
JT
Jump Trading Chicago, Illinois $150M AUM 17.61% 1-Year Est. Return
SCM
Stellar Capital Management Phoenix, Arizona $147M AUM 5.91% 1-Year Est. Return
HF
Hellman & Friedman San Francisco, California $169M AUM
SMFS
Squar Milner Financial Services Irvine, California $176M AUM 10.56% 1-Year Est. Return
CCM
Cloverdale Capital Management Dallas, Texas $135M AUM 13.89% 1-Year Est. Return
CCM
Castine Capital Management Boston, Massachusetts $129M AUM 23.45% 1-Year Est. Return

Stralem & Co's Q4 2017 Portfolio in Review

As of Q4 2017, Stralem & Co held 47 positions worth $589M, down 15% from $695M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Stralem & Co withdrew a net $122M in Q4 2017, closing 2 positions and reducing 38 holdings. Its most notable exit was Walt Disney, an estimated $18.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Stralem & Co added an estimated $3.8M to Celgene Corp.

  • Stralem & Co added most to Celgene Corp in Q4 2017, an estimated $3.8M increase.
  • Stralem & Co's biggest Q4 2017 reduction was Adobe, cutting an estimated $8.27M.
  • Stralem & Co fully exited Walt Disney in Q4 2017, selling an estimated $18.7M.
  • Stralem & Co's ten largest holdings make up 35% of its $589M portfolio in Q4 2017.
  • Stralem & Co opened 0 new positions and closed 2 in Q4 2017.
  • Stralem & Co's portfolio value fell 15% quarter-over-quarter to $589M.

Based on Stralem & Co's 13F filing for Q4 2017, filed 17 Jan 2018.